Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease
A trial was carried out to study the efficiency and safety of therapy with the new antiasthenic drug Ladasten. The findings suggest its high safety and efficiency and good tolerability of Ladasten in the treatment of asthenia and asthenic spectrum disorders, the development of which is associated wi...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Concilium Medicum
2010-03-01
|
Series: | КардиоСоматика |
Subjects: | |
Online Access: | https://cardiosomatics.orscience.ru/2221-7185/article/view/44966 |
_version_ | 1818616004151869440 |
---|---|
author | F. Yu Kopylov Yu. M Nikitina E. A Makukh A. L Syrkin |
author_facet | F. Yu Kopylov Yu. M Nikitina E. A Makukh A. L Syrkin |
author_sort | F. Yu Kopylov |
collection | DOAJ |
description | A trial was carried out to study the efficiency and safety of therapy with the new antiasthenic drug Ladasten. The findings suggest its high safety and efficiency and good tolerability of Ladasten in the treatment of asthenia and asthenic spectrum disorders, the development of which is associated with cardiovascular disease. |
first_indexed | 2024-12-16T16:42:54Z |
format | Article |
id | doaj.art-94d0b505957d439aa1b4ef14e954834d |
institution | Directory Open Access Journal |
issn | 2221-7185 2658-5707 |
language | English |
last_indexed | 2024-12-16T16:42:54Z |
publishDate | 2010-03-01 |
publisher | Concilium Medicum |
record_format | Article |
series | КардиоСоматика |
spelling | doaj.art-94d0b505957d439aa1b4ef14e954834d2022-12-21T22:24:16ZengConcilium MedicumКардиоСоматика2221-71852658-57072010-03-0111576140632Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular diseaseF. Yu KopylovYu. M NikitinaE. A MakukhA. L SyrkinA trial was carried out to study the efficiency and safety of therapy with the new antiasthenic drug Ladasten. The findings suggest its high safety and efficiency and good tolerability of Ladasten in the treatment of asthenia and asthenic spectrum disorders, the development of which is associated with cardiovascular disease.https://cardiosomatics.orscience.ru/2221-7185/article/view/44966cardiovascular pathologyastheniaantiasthenic means |
spellingShingle | F. Yu Kopylov Yu. M Nikitina E. A Makukh A. L Syrkin Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease КардиоСоматика cardiovascular pathology asthenia antiasthenic means |
title | Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease |
title_full | Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease |
title_fullStr | Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease |
title_full_unstemmed | Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease |
title_short | Study of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease |
title_sort | study of the efficiency and safety of ladasten therapy in patients with cardiovascular disease |
topic | cardiovascular pathology asthenia antiasthenic means |
url | https://cardiosomatics.orscience.ru/2221-7185/article/view/44966 |
work_keys_str_mv | AT fyukopylov studyoftheefficiencyandsafetyofladastentherapyinpatientswithcardiovasculardisease AT yumnikitina studyoftheefficiencyandsafetyofladastentherapyinpatientswithcardiovasculardisease AT eamakukh studyoftheefficiencyandsafetyofladastentherapyinpatientswithcardiovasculardisease AT alsyrkin studyoftheefficiencyandsafetyofladastentherapyinpatientswithcardiovasculardisease |